Analytics and brochures

For the attention of: heads of healthcare organizations which conduct clinical trials of medical products as well as R&D and registration units of producers/distributors of medical products.

Pepeliaev Group advises that the new Regulation No. 408-P  of the Central Bank of Russia (“CBR”) comes into force on January 31, 2014. This establishes a new procedure for the CBR to approve candidates for management positions at banks, as well as to attest to the business reputation of Board members and shareholders holding more that 10% of the shares in the bank in question.

Pepeliaev Group advises that the Federal Service for Surveillance in Healthcare (Roszdravnadzor) has issued Letter No. 16I-1595/13 “On informing Roszdravnadzor about holding scientific or other events” (the “Letter”).

Pepeliaev Group advises that the following laws have been adopted: No. 426-FZ “On special evaluation of work conditions” dated 28 December 2013 (the “Law on Special Evaluation”) and the law amending certain other federal laws including the Labour Code and the Code of Administrative Offences in connection with special evaluation of work conditions being introduced (No. 421-FZ “Law on Amendments” dated 28 December 2013).